Effectiveness of the Quotient® ADHD Assessment in a System of Care
Stopped early · Not applicable
Conditions studied: Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Disorder With Hyperactivity
In brief
The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.
Key facts
- Study ID
- NCT02094612
- Run by
- Kaiser Permanente
- People needed
- 207
- Starts
- 2014-03-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2017-07-17
Who can join
Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients within the specified age range who are English speaking and who are presenting for ADHD assessment are eligible. An additional criterion is consent to be randomized.
You may not qualify if…
- Non English speaking
- Refusal to participate
Where it is running
- Kaiser Permanente, Folsom — Folsom, California, United States
- Kaiser Permanente, Roseville — Roseville, California, United States
- Kaiser Permanente, Walnut Creek Medical Center — Walnut Creek, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.